Data & Technology

Why manufacturers should leverage technology to address low adherence rates.

Presentation offers insight on this aforementioned model that assists retail and specialty-lite brands.

Fireside chat uncovers ways to leverage this technology in order to boost medication adherence, engagement, and outcomes.

Under the group purchasing agreement, the serialization business will be the sole provider of DSCSA services for Premier’s 4,300-plus hospital and health system network.

The Asia-Pacific location is expected to provide serialization solutions for counterfeit medication entering the pharma supply chain.

A JAMA Network Open study dives into how the utilization of a digital patient portal changed during the COVID-19 pandemic, while also exploring ways that multimorbidity and socioeconomic disparities affected those statistics.

The offering reportedly helps avoid product quarantine.

The company’s cloud technology services aim to assist healthcare and pharma with AI integration.

OneScan 7.1 is expected to boost compliance, while also improving pharma supply chain efficiencies.

The partnership revolves around meeting various agency standards and industry requirements pertaining to the drug development and manufacturing lifecycle.

Personalized medicine approaches, informed by predictive modeling, could optimize treatment outcomes and reduce patient burden and costs.

The Masimo product is expected to address a significant gap in the market for dependable home-use medical devices.

Scientists develop algorithms that can not only identify tumors that will respond well to chemotherapy, but which are also likely to resist treatment.

The analysis notes that 60% of respondents were setting targets based on AI’s ability to either cut costs or boost productivity.

In this video interview with Associate Editor Miranda Schmalfuhs, Dr. Jo Varshney, CEO & Founder of VeriSIMLife, discusses how artificial intelligence and machine learning can assist in the drug shortage problem.

The era of big pharma as product-first companies must end, as services become the larger priority.

As technology continues to advance, investigators explore the legal protocol for how to handle AI-responsible injuries.

Offerings include treatment plans for a considerable number of illnesses and conditions, company says.

Study describes how a game theoretic model can successfully analyze how adoption of blockchain technology can reveal quality information.

A discussion of where cell and gene therapies are currently doing, what's on the horizon, personalization, and much more.

The predicted value is largely driven by manufacturers' prioritization of brand protection.

Bloomlife’s MFM-Pro enables healthcare providers to measure maternal and fetal heart rate in the patient's home or clinic.

EdenHelp is expected to provide HCPs and patients with real-time access to Rx drug and medical device information.

Researchers from the University of Cambridge collaborated with Pfizer to develop a platform combining automated experiments with artificial intelligence to predict chemical reactions.

Cureus report discuss the value of AI, but the medical community must remain aware of privacy pitfalls.